Announced on World Diabetes Day, the
national movement will travel across America in 2020 to educate and
activate communities around the connection between type 2 diabetes
and heart failure
AstraZeneca today announced the launch of Diabetes Can Break
Your Heart, a national movement with a goal to change the
trajectory of heart failure (HF) in type 2 diabetes (T2D). The
initiative is designed to raise awareness, create community action
and spark dialogue between those with T2D and their healthcare
providers to help reduce the risk of HF—one of the earliest and
most frequent cardiac complications for people living with T2D,
often before heart attack or stroke, and an urgent public health
issue.[1,2]
Diabetes Can Break Your Heart will travel to several cities
across America in 2020 to educate and activate communities around
the inherent link between T2D and HF. The tour will bring together
national and local advocacy organizations, key community leaders
and the public with the common goal of empowering the diabetes
community to demand more for their future.
Kiersten Combs, Vice President, US Cardiovascular &
Metabolic Disease at AstraZeneca said: “Heart failure presents a
serious threat to people living with type 2 diabetes, yet there is
a lack of understanding and awareness of this common complication.
While there is no cure for heart failure, there are important
actions that can be taken today to help prevent or delay this
complication of type 2 diabetes.[3,4] The Diabetes Can Break Your
Heart movement will look to drive this dialogue and empower those
living with type 2 diabetes to act early to optimally manage their
disease.”
At the core of the tour is the Diabetes Heartbreaker
virtual reality experience which uses immersive, cutting-edge
technology to heighten awareness of the T2D and HF connection. The
experience aims to spark a sense of urgency around the steps people
living with T2D can take today to help reduce their risk tomorrow.
In addition to the virtual reality experience, a traveling
airstream will be featured at each tour stop, offering educational
tools and resources, access to local policy makers, and the
opportunity to engage with the movement via digital platforms that
will be rolled out throughout 2020. Those living with T2D and/or HF
and their loved ones will also have the chance to share their
stories of wisdom, strength and resilience.
Several organizations have joined the movement to help expand
Diabetes Can Break Your Heart to local communities and nationwide
including the American Association of Clinical Endocrinologists
(AACE), American Association of Diabetes Educators (AADE),
Association of Black Cardiologists, Inc. (ABC), and Mended Hearts.
In addition, Diabetes Can Break Your Heart shares common goals with
Know Diabetes by Heart, a joint initiative of the American Heart
Association and the American Diabetes Association, which is
sponsored in part by AstraZeneca.
“People living with type 2 diabetes have a two-to-five times
greater risk of heart failure than those without type 2 diabetes,”
said Javed Butler, MD, MPH, MBA, Professor and Chairman, Department
of Medicine, University of Mississippi. “As medical professionals,
we have a responsibility to bring awareness to this inherent link –
and I’m proud to join the Diabetes Can Break Your Heart movement to
educate and empower patients to prevent heart failure sooner.”
The Diabetes Heartbreaker will make its public debut in the
AstraZeneca booth (1725) at the American Heart Association’s
Scientific Sessions 2019 in Philadelphia, the City of Brotherly
Love and Sisterly Affection, before hitting the road in 2020.
To learn more about the Diabetes Can Break Your Heart movement,
including the Airstream Local Market Tour, visit www.DiabetesHeartbreak.com.
– ENDS –
NOTES TO EDITORS
About Diabetes Can Break Your Heart
Diabetes Can Break Your Heart is a national movement with a goal
to change the trajectory of heart failure (HF) in type 2 diabetes
(T2D), offering a powerful declaration and rallying cry to raise
awareness, create community action and spark dialogue between those
with T2D and their healthcare providers to reduce the risk of
HF.
Diabetes Can Break Your Heart will travel across America in 2020
to educate and activate communities around the inherent link
between T2D and HF through an innovative and immersive experience.
The tour will bring together national and local advocacy
organizations, key community leaders and the public with the common
goal to empower the diabetes community to demand more for their
future. To learn more about the Diabetes Can Break Your Heart
movement, including the Airstream Local Market Tour, visit
www.DiabetesHeartbreak.com.
About the American Association of Clinical Endocrinologists
(AACE)
The American Association of Clinical Endocrinologists (AACE)
represents more than 6,500 endocrinologists in the United States
and abroad. AACE is the largest association of clinical
endocrinologists in the world. A majority of AACE members are
certified in endocrinology, diabetes and metabolism and concentrate
on the treatment of patients with endocrine and metabolic disorders
including diabetes, thyroid disorders, osteoporosis, growth hormone
deficiency, cholesterol disorders, hypertension and obesity. Visit
our site at www.aace.com.
About the American Association of Diabetes Educators (AADE)
AADE is an interdisciplinary professional membership
organization dedicated to improving prediabetes, diabetes and
cardiometabolic care through innovative education, management and
support. With more than 14,000 professional members including
nurses, dietitians, pharmacists, exercise specialists, and others,
AADE has a vast network of practitioners working with people who
have, are affected by or are at risk for diabetes. Learn more at
www.diabeteseducator.org, or visit us on Facebook (American
Association of Diabetes Educators), Twitter (@AADEdiabetes) and
Instagram (@AADEdiabetes).
About the Association of Black Cardiologists, Inc. (ABC)
Founded in 1974, the ABC is a nonprofit organization with an
international membership of more than 1,800 healthcare, lay
professionals, corporate and institutional members. The ABC’s
mission is to promote the prevention and treatment of
cardiovascular disease, including stroke, in Blacks and other
minorities and to achieve health equity for all through the
elimination of disparities. For more information on the NEW- HOPE
study and the Association of Black Cardiologists, visit
http://www.abcardio.org.
About Know Diabetes by Heart™
The American Heart Association and the American Diabetes
Association launched the collaborative landmark initiative called
Know Diabetes by Heart™ to comprehensively combat the national
public health impact of type 2 diabetes and cardiovascular disease.
Visit KnowDiabetesbyHeart.org for resources.
About Mended Hearts
Mended Hearts is the largest heart patient support network in
the world, with almost 30,000 members and 275 chapters. Recognized
for its role in facilitating a positive patient-care experience,
Mended Hearts partners with hospitals and cardiac rehab clinics to
offer support through visiting programs, group meetings and
educational forums. Mended Hearts inspires hope and improves
quality of life for heart patients and their families through
ongoing peer-to-peer support, education, and advocacy. Visit
www.mendedhearts.org and follow us on Facebook @Mendedhearts and
Twitter @MendedHearts.
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company
that focuses on the discovery, development and commercialization of
prescription medicines, primarily for the treatment of diseases in
three therapy areas - Oncology, Cardiovascular, Renal &
Metabolism and Respiratory. AstraZeneca operates in over 100
countries and its innovative medicines are used by millions of
patients worldwide. For more information, please visit
www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.
References
- Packer, M. Heart Failure: The Most Important, Preventable, and
Treatable Cardiovascular Complication of Type 2 Diabetes. Diabetes
Care 2018;41(1):11-13.
- Shah AD et al. Type 2 diabetes and incidence of cardiovascular
diseases: A cohort study in 1·9 million people. The Lancet Diabetes
& Endocrinology 2015;3(2):105–13.
- National Institutes of Health. National Heart, Lung, and Blood
Institute. Heart Failure.
https://www.nhlbi.nih.gov/health-topics/heart-failure. Last
accessed September 16, 2019.
- Centers for Disease Control and Prevention. Heart Failure Fact
Sheet.
https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_failure.htm.
Last accessed September 16, 2019.
- American Diabetes Association. 10. Cardiovascular Disease and
Risk Management: Standards of Medical Care in Diabetes—2019.
Diabetes Care. 2019;42(suppl 1): S103-S112.
- Roger, Véronique L. Epidemiology of heart failure. Circ Res.
2013;113(6):646-59.
US-33710 Last Updated 11/19
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191114005229/en/
Media Inquiries Michele Meixell +1 302 885 2677
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Apr 2024 to May 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From May 2023 to May 2024